Page last updated: 2024-11-05

3-quinuclidinol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

quinuclidin-3-Ol: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID15381
CHEMBL ID276310
CHEBI ID115239
SCHEMBL ID66150
MeSH IDM0450245

Synonyms (65)

Synonym
quinuclidin-3-ol
einecs 216-578-4
1-azabicyclo(2.2.2)octan-3-ol
3-quinuclidinol dl-form
nsc 93905
brn 0104327
974mvz0wok ,
unii-974mvz0wok
hsdb 7710
bdbm50047005
1-aza-bicyclo[2.2.2]octan-3-ol (3-quinuclidinol)
3-hydroxy-1-azoniabicyclo[2.2.2]octane
SDCCGMLS-0065888.P001
quinuclidine-3-ol
3-quinuclidinol ,
nsc-93905
1619-34-7
nsc93905
3-hydroxyquinuclidine
quinuclidinol
1-azabicyclo[2.2.2]octan-3-ol
3-quinuclidinol, 99%
inchi=1/c7h13no/c9-7-5-8-3-1-6(7)2-4-8/h6-7,9h,1-5h
3-hydroxy-1-azabicyclo[2.2.2]octane
(+-)-3-quinuclidinol
1-aza-bicyclo[2.2.2]octan-3-ol
CHEBI:115239 ,
CHEMBL276310 ,
(+/-)-3-quinuclidinol
FT-0650672
A810307
AKOS009158263
3-hydroxy quinuclidine
3-hydroxychinuclidin
1-azabicyclo[2.2.2.]octan-3-ol
Q0024
FT-0615867
FT-0689777
PS-5754
3-hydroxyquinuclidine, (+/-)-
3-quinuclidinol, (+/-)-
3-quinuclidinol dl-form [mi]
3684-26-2
3-quinuclidinol, dl-
CS-B0695
SCHEMBL66150
(rac.)-3-quinuclidinol
3-quinuclidol
(rs)-3-quinuclidinol
racemic quinuclidin-3-ol
(+/-)3-quinuclidinol
aza-bicyclo[2.2.2]oct-3-yl alcohol
(rs) 3-quinuclidinol
W-201469
quinuclidinol-3
Q27197086
mfcd00151326
3-oxyquinuclidine
quinuclidone-3
DTXSID50862716
F11430
SB13175
3-hydroxy chinuclidin
AB87536
PD060385
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (3)

ClassDescription
quinuclidines
tertiary amineA compound formally derived from ammonia by replacing three hydrogen atoms by hydrocarbyl groups.
secondary alcoholA secondary alcohol is a compound in which a hydroxy group, -OH, is attached to a saturated carbon atom which has two other carbon atoms attached to it.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (6)

Assay IDTitleYearJournalArticle
AID1612876Cytotoxicity against human RPE1 cells assessed as reduction in cell viability after 48 hrs by MTS assay2019European journal of medicinal chemistry, Feb-01, Volume: 163Discovery of novel quaternary ammonium compounds based on quinuclidine-3-ol as new potential antimicrobial candidates.
AID125789Inhibitory effect on Bufuralol 1'-hydroxylation by human liver microsomes (Ki = apparent inhibition constant)1993Journal of medicinal chemistry, Apr-30, Volume: 36, Issue:9
Development of a pharmacophore for inhibition of human liver cytochrome P-450 2D6: molecular modeling and inhibition studies.
AID52133Inhibition of [3H]-choline brain uptake was determined by in situ brain perfusion studies in male rats2004Bioorganic & medicinal chemistry letters, Jun-21, Volume: 14, Issue:12
Molecular modeling studies on the active binding site of the blood-brain barrier choline transporter.
AID1612875Cytotoxicity against human HeLa cells assessed as reduction in cell viability after 48 hrs by MTS assay2019European journal of medicinal chemistry, Feb-01, Volume: 163Discovery of novel quaternary ammonium compounds based on quinuclidine-3-ol as new potential antimicrobial candidates.
AID494749Inhibition of [3H]choline uptake at choline transporter 1 in mouse brain synaptosome2010Bioorganic & medicinal chemistry letters, Aug-15, Volume: 20, Issue:16
3-D-QSAR and docking studies on the neuronal choline transporter.
AID1612874Cytotoxicity against HEK293 cells assessed as reduction in cell viability after 48 hrs by MTS assay2019European journal of medicinal chemistry, Feb-01, Volume: 163Discovery of novel quaternary ammonium compounds based on quinuclidine-3-ol as new potential antimicrobial candidates.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (8.33)18.2507
2000's4 (33.33)29.6817
2010's7 (58.33)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 38.35

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index38.35 (24.57)
Research Supply Index2.56 (2.92)
Research Growth Index5.06 (4.65)
Search Engine Demand Index47.63 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (38.35)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]